Insulet (PODD) Interest Coverage Ratio (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.41% |
| Dec 31, 2025 | 30.14% |
| Sep 30, 2025 | 22.11% |
| Jun 30, 2025 | -35.99% |
| Mar 31, 2025 | -24.05% |
| Dec 31, 2024 | 78.88% |
| Sep 30, 2024 | 43.40% |
| Jun 30, 2024 | -6.83% |
| Mar 31, 2024 | -66.55% |
| Dec 31, 2023 | 201.67% |
| Sep 30, 2023 | 64.35% |
| Jun 30, 2023 | 8.80% |
| Mar 31, 2023 | 9.09% |
| Dec 31, 2022 | 756.92% |
| Dec 31, 2019 | -9.08% |
| Sep 30, 2019 | 82.43% |
| Jun 30, 2019 | -9.88% |
| Mar 31, 2019 | -53.39% |
| Dec 31, 2018 | 136.12% |
| Sep 30, 2018 | 69.02% |
| Dec 31, 2017 | -126.42% |
| Sep 30, 2017 | 162.09% |
| Jun 30, 2017 | 33.95% |
| Mar 31, 2017 | -31.67% |
| Dec 31, 2016 | -200.85% |
| Sep 30, 2016 | 293.81% |
| Jun 30, 2016 | 83.44% |
| Mar 31, 2016 | 38.01% |
| Dec 31, 2015 | 14.12% |
| Sep 30, 2015 | -7.02% |
| Jun 30, 2015 | -90.97% |
| Mar 31, 2015 | -700.95% |
| Dec 31, 2014 | 140.24% |
| Sep 30, 2014 | 28.85% |
| Jun 30, 2014 | -216.16% |
| Mar 31, 2014 | -965.57% |
| Dec 31, 2013 | 101.12% |
| Mar 31, 2013 | 4.80% |
| Dec 31, 2012 | 30.22% |
| Sep 30, 2012 | 20.22% |
| Jun 30, 2012 | 4.56% |
| Mar 31, 2012 | -0.03% |
| Dec 31, 2011 | -10.30% |
| Sep 30, 2011 | 22.15% |
| Jun 30, 2011 | -17.80% |
| Mar 31, 2011 | -220.45% |
| Dec 31, 2010 | 59.37% |
| Sep 30, 2010 | 16.90% |